BSE Sensex edges higher; Ranbaxy Laboratories, Sun Pharma gain
.jpg)
The BSE Sensex gains 0.36 per cent, while the Nifty is up 0.39 percent. Gains were led by value-buying in blue-chip stocks such as Oil and Natural Gas Corp after the stock fell sharply in the previous session. Oil & Natural Gas Corp (ONGC) gains 1.2 per cent after falling 5.8 per cent on Thursday.
Shares in Ranbaxy Laboratories Ltd are up 4.7 percent and Sun Pharmaceutical Industries gains 3.65 percent after the U.S. Food and Drug Administration approved the company's generic version of Novartis AG's blood pressure drug Diovan.
BSE healthcare index hits a record high for the second consecutive day by gaining as much as 2.4 percent to 11,251.51.
However, Asian shares were mostly in the red on Friday, weighed down by a weak performance on Wall Street and doubts about the strength of the U.S. economy, which pushed bonds higher.
(PTI) The benchmark BSE Sensex gained over 83 points in early trade today on the back of fresh buying by funds and retail investors after beginning of new settlement for July series in the derivatives segment amid easing of global crude oil prices.
The 30-share index, which had lost 306.23 points in the previous two sessions, recovered by 83.41 points, or 0.33 per cent, to 25,146.08 with healthcare, power, oil & gas and PSU sector stocks leading the rise.
On similar lines, the National Stock Exchange index Nifty rose 25.20 points, or 0.34 per cent, to 7,518.40.
Brokers said emergence of buying by participants amid beginning of new monthly settlement for July series in the derivatives segment and easing of crude oil prices in Asian trade influenced the sentiments here.
Among other Asian markets, Hong Kong's Hang Seng was down 0.24 per cent, while Japan's Nikkei fell 0.62 per cent in early trade today.
The US Dow Jones Industrial Average ended 0.13 per cent lower in yesterday's trade on disappointing economic data.
Other Latest News
.webp)
AAP supremo Arvind Kejriwal on Thursday intensified his criticism of the BJP-led central government, accusing it of failing to ensure law and order in Delhi.
Addressing a press conference at party office, Kejriwal said, "There is an atmosphere of fear and insecurity everywhere in Delhi. Women feel unsafe stepping out after 7 pm and parents worry about their daughters going outside."
.webp)
The High Court on Thursday refused to ban ISKCON's activities in Bangladesh, a local newspaper reported days after a lawyer was killed in a clash between security personnel and supporters of a Hindu leader arrested on sedition charges.
The lawyer had sought a ban from the high court on the International Society for Krishna Consciousness (ISKCON) after placing some newspaper reports related to the organisation on Wednesday.
.webp)
The Manipur government on Thursday announced that classes in schools and colleges in Imphal Valley districts and Jiribam would resume from November 28 after a hiatus of 13 days.
Educational institutes in these districts have remained closed since November 16 after the dead bodies of three women and three children in Jiribam were recovered from the Jiri and Barak rivers in Manipur and Assam respectively.
.webp)
Eknath Shinde, who served as chief minister in the outgoing Maharashtra government, is unlikely to accept the post of deputy CM in the new dispensation, his close aide Sanjay Shirsat said on Thursday.
Shirsat, an MLA and spokesperson of the Shiv Sena, however, said Shinde would be a part of the cabinet.
.webp)
Dr. Reddy’s announced the launch of Toripalimab in India on Thursday, for patients diagnosed with nasopharyngeal carcinoma (NPC), a rare form of head and neck cancer.
Toripalimab, a New Biological Entity (NBE), is the only immuno-oncology drug approved by regulatory authorities like the USFDA, EMA, and MHRA for treating adults with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). It is globally recognised for its efficacy in this indication, the Hyderabad-based company said in a statement.
.webp)
.webp)
.webp)
.webp)
.webp)
